Drupal.behaviors.print = function(context) {window.print();window.close();}>
Alnylam Presents Positive Phase I Data on Cholesterol Drug Candidate
April 26, 2012
Alnylam Presents Positive Phase I Data on Cholesterol Drug Candidate
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Oligo Drugs Advance in the Clinic in 2012 as Delivery Hurdles are Addressed
January 3, 2013 / Gene Silencing News
With Alnylam Settlement Money in Hand, Tekmira Plans 'Aggressive' Pipeline Advancement
November 15, 2012 / Gene Silencing News
Tekmira Management Offers Pipeline Update, Reiterates Claim to Disputed Delivery Technology
March 29, 2012 / Gene Silencing News
UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 23, 2013 / Gene Silencing News
Alnylam Releases Proof-of-concept Data on Preclinical Porphyria Drug
May 23, 2013 / Gene Silencing News